Superoxide dismutase and Naproxen® in the very late phase of carrageenan induced edema in rats

Revista de Investigacion Clinica

Volumn 52, Issue 2, 2000, Pages 156-160

  García González, Adolfo ^a   Morales Hernández, Roberto C ^b   Porta Gándara, Miguel A ^b   Rubio Cerda, Eduardo ^b   Ochoa, José Luis ^b  

^a Hospital General de Zona IMSS   (Mexico)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS DEL NOROESTE   (Mexico)

Author keywords

Anti inflammatory; Carrageenan; Plethysmometer; Rats; Superoxide dismutase

Indexed keywords

CARRAGEENAN; FREE RADICAL; LEUKOTRIENE; MERCURY; NAPROXEN; PLACEBO; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; EDEMA; ENZYME ACTIVITY; NONHUMAN; PLETHYSMOGRAPHY; RAT; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; EDEMA; FREE RADICAL SCAVENGERS; NAPROXEN; PLETHYSMOGRAPHY; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SUPEROXIDE DISMUTASE;

EID: 1642633565     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol 1962; 111: 544-7.
2. Rodt SA, Reed RK. Interstitial fluid pressure in rat skin becomes more negative in the initial phase of carrageenan induced edema. Int J Microcirc Clin Exp 1993; 12: 299-312.
3. Jadot G, Michelson AM, Puget K. Anti-inflammatory activity of superoxide-dismutases: inhibition of carrageenan induced edema in rats. Free Rad Res Commun 1986; 1: 395-403.
4. Herrera JE, Herrera A, Cortés JC. Estudio comparativo del efecto anti-inflamatorio de Wobenzym vs naproxen o salina, en el modelo de inflamación experimental inducida por inyección subcutánea de carragenina en la rata. Reporte Técnico. Laboratorios ROMSA SA. Mucos Pharma GmbH and Co. (Germany). Julio. 1992.
5. Vinegar R, Traux JF, Selph JL. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc 1987; 46: 118-26.
6. Bulkey GB. The role of oxygen free radicals in human disease processes. Surgery 1983; 94: 407-11.
7. McCord JM, Fridovich I. Superoxide-dismutase, an enzymic function for erythrocuprein. J Biol Chem 1969; 244: 6049-55.
8. Michelson AM, Puget K, Jadot G. Anti-inflammatory activity of superoxide-dismutases: comparison of enzymes from different sources in different models in rats: mechanism of action. Free Rad Res Comm 1986; 2: 43-56.
9. Oyanagui Y, Sato S, Inoue M. Inhibition of carrageenan-induced edema superoxide-dismutase that binds to heparan sulfates on vascular endotelial cells. Biochem Pharmacol 1991; 42: 991-5.
10. Autor PA. Clinical applications of free radicals scavengers. In: Autor PA ed. Pathology of oxygen. New York; Academic Press. 1982: 123-61.
11. Weissman G. The actions of NSADs. Hospital practice 1991; 42: 60-76.
12. Oaulus H, Bulpitt K. Non-steroidal anti-inflammatory agents and corticosteroids. In: Scumacher HR, Kippel JH Koopman WJ eds. Primer of the Rheumatic Diseases. The Arthritis Foundation. Atlanta GA 10th ed. 1993: 298-303.
13. Cremer M. Type II collagen-induced arthritis in rats. In: CRC handbook of animal models for rheumatic diseases. CRC Press Boca Raton FL. 1st ed. 1998: Vol. I: 17-27.
14. Sloboda AE, Birnaum JE, Oronsky AL, Kerwar SS. Studies on type II collagen-induced polyarthritis in rats. Effect of anti-inflammatory and antirheumatic agents. Arth Rheum 1981; 24: 616-24.
15. Alspaugh MA, Van Hoosier GL. Naturally occurring and experimentally induced arthritis in rodents: a review of the literature. Lab Animal Sci 1973; 23: 724-42.
16. Dorland's illustrated medical dictionary. Philadelphia. Saunders WB. 1974. 25th Ed.
17. Hayashi M, Matsunaga K, Okahara A. Effect of bucillamine (SA96) on type II collagen-induced arthritis in rats. J Rheumatol 1991; 18: 691-5.
18. Vaille A, Jadot G, Elizagaray A. Anti-inflammatory activity of various superoxide-dismutases on polyarthritis in the Lewis rat. Biochem Pharmacol 1989; 39: 247-55.
19. Morales RC, Moreno LC, Porta MA, Rubio E. Pletismógrafo de mercurio. Memorial del XIII Congreso de Instrumentación. Sociedad Mexicana de Intrumentación AC. Ensenada BC, México. Oct. 1988: 731-5.
20. Michelson AM, Jadot G, Puget K. Mechanism of anti-inflammatory activity of superoxide-dismutases. In: Hayashi O, Imunura S, Miyachi Y, eds. The biological role of reactive oxygen species in skin. Tokyo: University of Tokyo Press, 1987: 199-210.
21. Helmut S. Oxidative stress: from basic research to clinical application. Am J Med 1991; 91(S-3C): 31-7.
22. Cohen M. Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials? Ann Int Med 1989; 111: 918-31.
23. Salin ML, McCord JM. Free radicals and inflammation. Protection of phagocytosing leukocytes by superoxide-dismutase. J Clin Invest 1975; 56: 1319-23.
24. Greenwald RA. Oxygen radicals, inflammation and arthritis: pathophysiological considerations and implications for treatment. Sem Arthr Rheum 1991; 20: 219-40.
25. Puig-Parellada P, Planas JM. Synovial fluid degradation induced by free radicals. In vitro action of several free radicals and anti-inflammatory drugs. Biochem Pharmacol 1978; 27: 535-7.
26. Oyanagui Y. Steroid-like anti-inflammatory effect of superoxide-dismutase in serotonin-, histamine-, and kinin-induced edemata of mice: existence of vascular permeability regulating protein(s). Biochem Pharmacol 1981; 30: 1791-8.